James Gute
Chief Commercial Officer, Interim CEO & Interim PresidentMr. James Gute is Interim CEO & Interim President of Quanterix Corporation from November 18, 2026 and also serves as its Chief Commercial Officer since August 2026. Mr. Gute joined the Quanterix Corporation in August 2026. Prior to his tenure at Quanterix, he held several leadership positions in the diagnostics and healthcare industry. From August 2024 to August 2026, Mr. Gute was Senior Vice President and Commercial Manager, General Screening at Exact Sciences (now Abbott Laboratories, Cancer Diagnostics). Before that, he served as General Manager, Western Region at the same organization from January 2022 to August 2024. Mr. Gute’s earlier career includes in his tenure at GE Healthcare, where he held multiple roles of increasing responsibility, culminating in his position as President of the North Central Region.
Positions
- Company NameQuanterix CorporationStock CodeQTRXPositionChief Commercial Officer, Interim CEO & Interim PresidentColleagues
- WPWilliam P. DonnellyExecutive Chair
- DRDavid R. WaltCo-Founder & Chairman of Scientific Advisory Board
- JGJames GuteChief Commercial Officer, Interim President & Interim CEO
- JFJason FaesslerCFO & Treasurer
- KAKaren A. FlynnIndependent Director
- JTJeffrey T. ElliottLead Independent Director
- IMIvana Magovcevic-LiebischIndependent Director
